Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AVICCI feasibility study of cenicriviroc intensification for HIV-associated cognitive impairment
ISRCTN18166185Phase 2Completed
- Sponsor
- Imperial College London
- Start
- Oct 2015
- Modality
- Small Molecules
01
Overview
Phase 2, open-label, single-arm trial of cenicriviroc in human immunodeficiency virus infection (HIV), sponsored by Imperial College London. Primary endpoints: Acceptability, Pharmacokinetic results and 1 more. Started Oct 2015; status: completed.
02
Drugs
cenicriviroc
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on ISRCTN18166185.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN18166185.